Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 715-722

  Marchbank, Tania ^a   Chinery, Rebecca ^b   Hanby, Andrew M ^c   Poulsom, Richard ^c   Elia, George ^c   Playford, Raymond J ^a,d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Royal College of Surgeons

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; MESSENGER RNA;

ADULT; ARTICLE; CELL CULTURE; CELL DIVISION; CELL MOTION; DRUG EFFECT; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; PATHOPHYSIOLOGY; REFERENCE VALUE; REGENERATION; STOMACH; STOMACH ULCER; TISSUE DISTRIBUTION;

ADULT; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; REFERENCE VALUES; REGENERATION; RNA, MESSENGER; STOMACH; STOMACH ULCER; TISSUE DISTRIBUTION; TRYPSIN INHIBITOR, KAZAL PANCREATIC;

EID: 0030091962     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kazal LA, Spicer DS, Brahinsky RA: Isolation of a crystalline trypsin inhibitor-anticoagulant protein from the pancreas J Am Chem Soc 1948, 70 304-340
2. Playford RJ, Batten JJ, Freeman TC, Beardshall K, Vesey D, Fenn GC, Baron JH, Calam J Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol. Gut 1991, 32:1396-1400
3. McKeenan WL, Sakagami Y, Hoshi H: Two apparent human endothelial cell growth factors from hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 1986, 261:5378-5383
4. Freeman TC, Curry BJ, Calam J, Woodburn J: Pancreatic secretory trypsin inhibitor stimulates the growth of pancreatic tumour cells Gastroenterology 1990, 99: 1414-1420
5. Playford RJ, Hanby AM, Quinn C, Calam J: Influence of inflammation and atrophy on pancreatic secretory trypsin inhibitor (PSTI) levels within the gastric mucosa. Gastroenterology 1994, 106.735-741
6. Freeman TC, Playford RJ, Quinn K, Beardshall K, Calam J. Pancreatic secretory trypsin inhibitor in gastro-intestinal mucosa and gastric juice Gut 1990, 31: 1318-1323
7. Guesdon JL, Ternyck T, Avrameas S: The use of avidin/ biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979, 51:654-655
8. Yamamoto T, Nakamura Y, Nishide T, Emi M, Ogawa M, Mori T, Matsubara K: Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA Biochem Biophys Res Commun 1985, 132:605-612
9. Senior PV, Critchley DR, Beck F, Walker RA, Varley JM: The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse. an in situ hybridisation and immunohistochemical study. Development 1988, 104.431-446
10. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 1987, 162 156-159
11. Playford RJ, Marchbank T, Chinery R, Thim L, Hanby AH Human spasmolytic polypeptide is a cytoprotective agent which stimulates cell migration. Gastroenterology 1995, 108 108-116
12. Sato Y, Rifkin DP: Inhibition of endothelial cell movement by pericytes and smooth muscle cells. activation of latent transforming growth factor β1 like molecules by plasmin during co-culture. J Cell Biol 1989, 109-309-315
13. Gullick WJ, Hughes CM, Mellon K, Neal DE, Lemoinc NR: Immunohistochemical detection of the epidermal growth factor receptor in parrafin-embedded tissue. J Pathol 1991, 164:284-289
14. Williamson KE, Hamilton PW, Grimes J, Gilliland R: Advances in cell kinetics Br Med J 1991, 303 855-856
15. Scheving LA. Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor and members of the porcine secretin family. Arch Biochem Biophys 1983, 226.411-413
16. Fukayama M, Hayashi Y, Koike M Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal pancreatic and extrapancreatic tissues. J Histochem Cytochem 1986, 34 227-235
17. Shibata T, Ogawa M, Takata N: Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa. Res Commun Pathol Pharmacol 1987, 55:243-248
18. Marks WH, Ohlsson K: Elimination of pancreatic secretory trypsin inhibitor from the circulation. Scand J Gastroenterol 1983, 18:955-959
19. Playford RJ, Batten JJ, Freeman TC, Beardshall K, Vesey D, Fenn GC, Baron JH, Calam J. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol. Gut 1991, 32 1396-1400
20. Silen W. Gastric mucosal defence and repair Physiology of the Gastrointestinal Tract, ed 2. Edited by LR Johnson. New York, Raven Press, 1987, pp 1044-1069
21. Chinery R, Playford RJ: Combined intestinal trefoil factor and epidermal growth Factor is prophylatic against indomethacin-induced gastric damage in the rat. Clin Sci 1995, 88:401-403
22. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution central role of transforming growth factor β Gastroenterology 1993, 105. 1323-1332
23. Fukuoka S-I, Fushiki T, Kitagawa Y, Sugimoto EI: Competition of a growth stimulating-/cholecystokinin (CCK) releasing peptide (monitor peptide) with epidermal growth factor binding to 3T3 fibroblasts. Biochem Biophys Res Commun 1987, 145.646-650
24. Niinobu T, Ogawa M, Murata A, Nishijima J, Mori T Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor. J Exp Med 1990, 172:1133-1142